EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benchmarking Molecular Mutation Operators for Evolutionary Drug Design

Raúl Acosta Murillo iD, Patricio Adrián Zapata-Morin iD, José Carlos Ortiz-Bayliss iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Raúl Acosta Murillo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, School of Biological Sciences, Universidad Autónoma de Nuevo León, Pedro de Alba SN, San Nicolás de los Ga…. Hauptthemen laut MEDLINE: Mutation, Drug Design. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates and compares different molecular mutation strategies to optimize their application as genetic algorithm operators in drug design. We evaluated five distinct mutation methods—Graph-Based Genetic Algorithm, Graph-Based Generative Model, SmilesClickChem, SELFIES Token, and SMILES Token Mutation—by assessing their computational efficiency, validity, and impact on molecular complexity and structural conservation. Our results reveal that the Graph-Based Genetic Algorithm achieves the highest molecular validity (96.5%) while maintaining computational efficiency, making it ideal for rapid iterative drug discovery. SmilesClickChem and Graph-Based Generative Model tend to increase molecular complexity, whereas SF-T simplifies molecular structures, suggesting different applications in lead optimization. Additionally, we analyzed mutation-induced changes in pIC50 potency and found that SELFIES Token caused the most substantial shifts in bioactivity, particularly in SRC-targeted molecules. These findings underscore the importance of selecting the appropriate mutation strategy to balance validity, structural diversity, and computational cost in AI-driven drug design. Our insights help refine evolutionary algorithms for molecular generation and optimize candidate selection in early-stage drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationDrug DesignAlgorithmsBenchmarkingDrug DiscoveryHumansEvolution, Molecular

Stichwörter der Autor:innen

computer-aided drug designgenetic operatorsmolecule mutationmolecule recombination

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, School of Biological Sciences, Universidad Autónoma de Nuevo León, Pedro de Alba SN, San Nicolás de los Garza 66455, Nuevo Leon, Mexico.
  • Tecnologico de Monterrey, School of Engineering and Sciences, Eugenio Garza Sada 2501 Sur, Monterrey 64700, Nuevo Leon, Mexico.

ORCID-Profile: Raúl Acosta Murillo, Patricio Adrián Zapata-Morin, José Carlos Ortiz-Bayliss

Zitieren

APA

Acosta Murillo, R., Zapata-Morin, P. A., & Ortiz-Bayliss, J. C. (2025). Benchmarking Molecular Mutation Operators for Evolutionary Drug Design. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311685

Vancouver

Acosta Murillo R, Zapata-Morin PA, Ortiz-Bayliss JC. Benchmarking Molecular Mutation Operators for Evolutionary Drug Design. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311685

BibTeX
@article{AcostaMurillo2025,
  author = {Acosta Murillo, Raúl and Zapata-Morin, Patricio Adrián and Ortiz-Bayliss, José Carlos},
  title = {Benchmarking Molecular Mutation Operators for Evolutionary Drug Design},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311685}
}
Kostenlos starten →